NO151860C - Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol - Google Patents

Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol

Info

Publication number
NO151860C
NO151860C NO770286A NO770286A NO151860C NO 151860 C NO151860 C NO 151860C NO 770286 A NO770286 A NO 770286A NO 770286 A NO770286 A NO 770286A NO 151860 C NO151860 C NO 151860C
Authority
NO
Norway
Prior art keywords
dinatrum
carboxycromon
yloxy
propan
bis
Prior art date
Application number
NO770286A
Other languages
English (en)
Other versions
NO770286L (no
NO151860B (no
Inventor
Kenneth Brown
Neil Arthur Stevenson
William Francis Kirk
Clive Booles
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO151860(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NO770286L publication Critical patent/NO770286L/no
Publication of NO151860B publication Critical patent/NO151860B/no
Publication of NO151860C publication Critical patent/NO151860C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
NO770286A 1976-01-30 1977-01-28 Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol NO151860C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (3)

Publication Number Publication Date
NO770286L NO770286L (no) 1977-08-02
NO151860B NO151860B (no) 1985-03-11
NO151860C true NO151860C (no) 1985-06-19

Family

ID=26238506

Family Applications (2)

Application Number Title Priority Date Filing Date
NO770286A NO151860C (no) 1976-01-30 1977-01-28 Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol
NO780183A NO780183L (no) 1976-01-30 1978-01-18 Fremgangsm}te til fremstilling av et dinatrium-kromoglykatmateriale

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO780183A NO780183L (no) 1976-01-30 1978-01-18 Fremgangsm}te til fremstilling av et dinatrium-kromoglykatmateriale

Country Status (14)

Country Link
JP (1) JPS5294411A (no)
AU (1) AU512593B2 (no)
DE (1) DE2703119A1 (no)
DK (2) DK154766C (no)
ES (1) ES455478A1 (no)
FI (1) FI770215A (no)
FR (1) FR2339604A1 (no)
IE (1) IE44760B1 (no)
IL (1) IL51314A (no)
LU (1) LU76661A1 (no)
NL (1) NL185446C (no)
NO (2) NO151860C (no)
NZ (1) NZ183157A (no)
SE (2) SE442268B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
JPS63138228U (no) * 1987-03-05 1988-09-12
JPS63138229U (no) * 1987-03-05 1988-09-12
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
CA2455115C (en) 1991-12-12 2008-05-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
NZ246421A (en) 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (no) * 1956-03-21 1900-01-01
BE556587A (no) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NL7700911A (nl) 1977-08-02
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
IL51314A (en) 1980-03-31
SE7700888L (sv) 1977-07-31
DK357588A (da) 1988-06-29
DK154766B (da) 1988-12-19
IE44760L (en) 1977-07-30
JPS6129929B2 (no) 1986-07-10
NL185446B (nl) 1989-11-16
FR2339604B1 (no) 1980-12-05
SE442268B (sv) 1985-12-16
DK154766C (da) 1989-05-22
LU76661A1 (no) 1977-08-03
NO770286L (no) 1977-08-02
DK156876B (da) 1989-10-16
NZ183157A (en) 1979-08-31
NO151860B (no) 1985-03-11
SE8107278L (sv) 1981-12-04
FI770215A (no) 1977-07-31
SE442267B (sv) 1985-12-16
DE2703119A1 (de) 1977-08-04
DK156876C (da) 1990-03-12
FR2339604A1 (fr) 1977-08-26
AU512593B2 (en) 1980-10-16
JPS5294411A (en) 1977-08-09
DE2703119C2 (no) 1990-10-25
NO780183L (no) 1977-08-02
NL185446C (nl) 1990-04-17
ES455478A1 (es) 1978-02-01
AU2162677A (en) 1978-08-03
IE44760B1 (en) 1982-03-24
DK357588D0 (da) 1988-06-29

Similar Documents

Publication Publication Date Title
NO151860C (no) Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
IT1082522B (it) Procedimento per la preparazione di tetraidofurano
IT1080207B (it) Procedimento per la preparazione di benzotiazoli
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE426833B (sv) Forfarande for framstellning av nya gona-4,9(10)-diener
IT1085033B (it) Procedimento per la preparazione di metossi-psorali
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
IT1076788B (it) Procedimento per preparare organopolisilossani
SE7704139L (sv) Forfarande for framstellning av azofergemnen
MX4161E (es) Procedimiento de preparacion de compuestos de amino-alcoxi-4(2h)-piranona-2,3 substituidos condensados-5,62
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
IT1143732B (it) Procedimento per la preparazione di etinil-beta-ionolo
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
IT1065800B (it) Procedimento per preparare trimetil-3,5,5 cicloesen-2 dione-1,4
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
IT1125157B (it) Procedimento per la preparazione di composti,'-dialogeno etilaromatici
IT1085377B (it) Procedimento per la preparazione di esafluoropropanone-2
IT1074317B (it) Procedimento per preparare alogenoacetali partendo da esterli
IT1079470B (it) Procedimento per la produzione di 1,2-dicloalcandioni
IT1091568B (it) Procedimento migliorato per la produzione di 5-nitroso-2,4,6-triammino-porimidina